PATENT CLAIM ANALYSIS

Application Number: 15753513
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["514", "245000"]

Abstract:
Provided herein are methods for identifying and treating subjects having conditions involving aberrant Ku70/80 activity. In particular, the invention relates to small-molecules which function as inhibitors of Ku70/80 protein and the non-homologous end-joining (NHEJ) pathway, and their use as therapeutics for the treatment of cancer and other diseases.

Claim (Index 24):
The kit of  claim 23 , wherein said compound is to be administered together with one or more anticancer agents.

Metadata:
- Claim Count in Document: 43.0
- Percentile: 88.0
- Lexical Diversity: 1.25581
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13783785', '14793878', '12324030', '11524528', '10576818']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7972750119821158
- 35 USC 102 Novelty (BERT): 0.5160410924805549
- Combined Prediction Score: 0.7691516200319597
- Mean Citation Score: 294.099174
- Max Citation Score: 302.82474
- Similarity Product: 221.8548836805868

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test